(Q33846647)

29 July 2017

1 reference

title

Antiviral therapy for chronic hepatitis B and C. Which patients are likely to benefit from which agents? (English)

1 reference

29 July 2017

1 reference

S C Gordon

1

1 reference

PubMed ID

10689413

29 July 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

29 July 2017

Postgraduate Medicine

1 reference

29 July 2017

107

1 reference

29 July 2017

2

1 reference

29 July 2017

135-8, 141-4

1 reference

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

29 July 2017

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.02.871

The long-term course of chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.02.871

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.02.871

Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.02.871

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.02.871

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.02.871

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2000.02.871

21 January 2018

Identifiers

DOI

10.3810/PGM.2000.02.871

1 reference

29 July 2017

1 reference

PubMed ID

10689413